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Conclusions: This study revealed that low bifurcation angle between LM and LAD had
an adverse clinical impact after single cross over LM to LAD stenting.
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Background: Objective: To evaluate the impact of bifurcation characteristics on
long-term clinical outcome after distal left main (LM) percutaneous coronary intervention
(PCI) with a provisional side-branch (SB) stenting strategy. Background: Provisional SB
stenting provides good results for patients with distal LM undergoing PCI. It is the
preferred strategy in cases where a single ostium is involved (LAD or LCX). This strategy
has never been specifically evaluated in more complex lesions involving the two side
branches (medina 1.1.1).
Methods: Methods: Individual data of patients with distal LM lesions included in the
French Taxus, Friend, Lemax and large centers registries and treated with a provisional
SB stenting strategy were analysed.
Results: Results: A total of 454 patients were included, 199 (43.8%) with a 1.1.1
bifurcation and 255 patients (56.2%) with any other type of bifurcation. Patients with a
medina 1.1.1 had a higher Syntax score (2810.2 vs. 21.98.7; p0.0001) and were
treated with a higher rate of SB stenting (45.7% vs. 14.5%; p0.0001) compared to other
lesion types. At multivariate logistic regression analysis, after adjustment for patient and
procedure confounders, a medina class 1.1.1 emerged as a predictor of 36 months’ MACE
(odd ratio: 2.332, 95% confidence interval 1.416 to 3.3841; p0.001) and death (odd
ratio: 3,689, 95% confidence interval 1.658 to 8.205).
Conclusions: Conclusion: In this observational study, patients with Medina 1.1.1 LM
lesions have worse baseline characteristics and clinical outcome compared to other lesion
types. Even after adjustment for data confounders Medina 1.1.1 remained associated with
a worse outcome suggesting that Medina 1.1.1 is by itself a risk factor.
1.1.1 Others p value
MACE 51 (25.6%) 36 (14.1%) 0.002
TVR 23 (11.6%) 19 (7.5%) 0.138
MI 10 (5%) 9 (3.5%) 0.430
Death 27 (13.6%) 11 (4.3%) 0.0001
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Background: Previous trials indicated that radial access was superior to conventional
femoral access for percutaneous coronary intervention in reducing bleeding and vascular
complications in patients with acute coronary syndrome (ACS). However, the overall
safety and efficacy of transradial coronary intervention (TRI) with drug eluting stent
(DES) versus coronary artery bypass grafting (CABG) for patients with unprotected left
main disease (UPLM) presenting with ACS is unknown.
Methods: All consecutive patients with ACS undergoing TRI with DES (n231) or
CABG (n357) for UPLM lesions in our center, between March 2008 and December
2010, were included. And a propensity-score matching was performed to adjust for
differences in baseline clinical and angiographic characteristics between the two cohorts,
yielding 154 pairs of matched patients.
Results: Median clinical follow-up duration was 26 months. Patients undergoing CABG
had higher unadjusted rates of all cause mortality, stroke, and myocardial infarction (MI).
After propensity-score adjustment, baseline comorbidities and angiographic characteris-
tics were similar between two groups. And no significant difference was observed
between TRI and CABG group in all cause mortality (4.5% vs. 6.5%; P 0.454) and MI
(5.2% vs. 7.8%; P  0.355). However, there was a significant increase in the incidence
of stroke in CABG group (0 vs. 2.6%; P0.044), while a significantly increased target
vessel revascularization (TVR) rate (13.0% vs. 5.2%; P  0.017) was observed in TRI
group. Composite outcome (death/MI/stroke) was comparable between the TRI and
CABG groups (7.1% vs. 12.3%; P  0.124). And the overall major adverse cardiac and
cerebral events including death/MI/stroke/TVR were more frequently developed in
patients undergoing TRI (18.2% vs. 15.6%; P  0.543). These findings were still
consistent after adjustment by SYNTAX score with or without propensity score, and
propensity score alone in Cox regression analysis.
Conclusions: TRI with DES on UPLM disease for ACS patients are comparable to
CABG in composite safety outcomes including death/MI/stroke. However, CABG is still
superior to percutaneous coronary intervention in TVR despite using DES.
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Background: The effectiveness of left main coronary artery (LMCA) percutaneous
coronary intervention (PCI) is inferior to coronary artery bypass surgery (CABG), mostly
due to the higher risk of repeat revascularization. The LMCA has typically been treated
as a single entity in studies comparing PCI and CABG. However, interventionalists
recognize that there are differences in the technical complexity of LMCA PCI depending
upon the lesion’s location. The influence of lesion location on outcomes is not clear.
Methods: We performed a systematic review and meta-analysis of percutaneous
drug-eluted stent (DES) implantation in ostial and trunk versus distal unprotected LMCA
lesions. Our co-primary endpoints were the incidence of major adverse cardiac events
(MACE) and target lesion/vessel revascularization (TLR/TVR). We included studies that
enrolled 100 patients and had 6 months follow-up.
Results: We identified 11 studies involving 4,236 patients. Mean duration of follow-up
was 26 months (range 20-36). We adopted the random effect model when computing the
combined hazard ratio (HR) (test for heterogeneity p 0.001). Compared with non-distal
stenting, distal LMCA PCI was associated with increased MACE (17.7%; 175/986 versus
25.6%; 576/2242) [HR (95% CI)- 2.07 (1.47-2.92)] and TLR/TVR (8.4%; 163/1931
versus 15.7%; 363/2305) [HR (95% CI)- 3.09 (2.02-4.73)] (figure).
Conclusions: Patients with ostial and trunk LMCA lesions treated with DES have better
outcomes than patients with distal lesions. Our findings may support unprotected
non-distal LMCA stenting as a primary approach in selected patient subsets.
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